Trial intelligence / Profile preview

XPF-001 in dental pain

NCT00954356Phase 2Completed

Sponsor
Xenon Pharmaceuticals
Start
Sep 2009
Primary completion
Nov 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of funapide in odontalgia, sponsored by Xenon Pharmaceuticals. Started Sep 2009; status: completed.

02

Drugs

funapide
03

Conditions

odontalgia

Beyond the preview

Go deeper on NCT00954356.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00954356.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call